天津招聘

Title: Group leader - immunology
Location: Chengdu, Sichuan
Job Category: Research and development
Employee Status: Full-time
Position: 1

Huiyu Research Institute is seeking a group leader in immunology to help us advance in
immuno-oncology and to develop therapeutic hypotheses from target identification,
pathway validation, therapeutic development and beyond. The candidate must be
independent and goal oriented, and able to efficiently lead teams and complete
multiple projects in parallel. The position will require creativity, resourcefulness, and
adaptability.The candidate will be responsible for the direction and execution of
projects, including novel assay development, in vitro proof-of concept, and in vivo
translational studies, and aligning the scientific plan with corporate objectives. We are
searching for enthusiastic, innovative, and highly motivated individuals who are
comfortable working in a fast-paced entrepreneurial environment.

Responsibilities
? Design experimental plans for pathway validation and target identification,
including assay development in vitro and in vivo, in collaboration with the
scientific team.
? Execute experiments, interpret and validate results, and communicate data to
scientific team and executive management
? Lead and collaborate with other scientists and research associates to achieve
company objectives
? Manage external research relationships with academic and commercial partners

Qualifications
? PhD or equivalent in the biological sciences, bioengineering, or related field.
? 5+ years of relevant laboratory experience, in academic, pharmaceutical or
biotechnology settings.
? Demonstrated ability in working with highly skilled teams in a fast-paced,
entrepreneurial and technical setting.
? Immunologist with a focus on target discovery. Research experience in immune
oncology
Strong experimental skills, especially assay development (in vitro & in vivo
models), cell and molecular immunology. Expertise in multi-color flow cytometry
immune cell phenotyping, tissue isolation techniques and assays
?Motivated and curious, experienced working with highly technical projects and
personnel.
? Highly adaptable and responsive to technical and business opportunities and
needs – comfortable delivering against challenging commitments.
Excellent communication and presentation skills, capable of conveying technical
information in a clear and thorough manner.
? PhD or equivalent in the biological sciences, bioengineering, or related field.
5+ years of relevant laboratory experience, in academic, pharmaceutical or
biotechnology settings.
? Demonstrated ability in working with highly skilled teams in a fast-paced,
entrepreneurial and technical setting.

四川汇宇制药股份有限公司 企业介绍

    四川汇宇制药股份有限公司生产基地位于四川省内江经济技术开发区内，占地面积10万平方米,项目总投资10亿元人民币，致力于高端抗肿瘤药物的研发，生产和销售。公司在四川成都双流区“天府国际生物城”设立全球创新药研发中心，将打造抗体抗癌创新药物研发总部及产业化基地，建设包括从事靶向抗肿瘤小分子化学药和大分子生物药研发、中试及产业化的研发中心，占地面积60亩，规划建筑面积88000平方米，可容纳1500名研发人员，计划在2022年建成运行。
    公司以科技创新为导向的发展理念，不断完善小分子化学药物和单克隆抗体生物药物两个技术平台，开发抗肿瘤领域的创新药物，公司一期项目可年产3000万瓶抗癌针剂，实现年产值25亿元人民币。公司的抗癌针剂于2014年通过英国GMP认证，并于同年顺利通过中国GMP认证。2015年7月公司获得欧盟药品放行资质，公司生产的抗癌针剂已经在伊丽莎白女王医院、皇家伦敦医院和剑桥大学附属医院等1200多家欧盟医院作为一线抗癌药物大规模使用。
    公司在美国、英国、法国、澳大利亚、加拿大、中国香港等全球80多个国家和地区建立了销售渠道并启动了当地的药品注册工作，已逐步建立并完善遍布全球的销售网络。同时以致力于改善人类健康为崇高宗旨，以‘关爱生命，追求卓越，简单诚信’为价值导向， 力争把公司打造成一家受人尊敬的国际化制药企业。